
Sign up to save your podcasts
Or


Abbott Labs hits a new all-time high after the FDA approves the company’s rapid Covid-19 test. Tiffany and Dollar General issue 2nd-quarter reports, offering an interesting look at both ends of the retail spectrum. Jim Gillies analyzes those stories, and shares some compelling reasons why investors looking for steady yield should take a closer look at the “Big Five” banks in Canada.
By The Motley Fool4.7
16041,604 ratings
Abbott Labs hits a new all-time high after the FDA approves the company’s rapid Covid-19 test. Tiffany and Dollar General issue 2nd-quarter reports, offering an interesting look at both ends of the retail spectrum. Jim Gillies analyzes those stories, and shares some compelling reasons why investors looking for steady yield should take a closer look at the “Big Five” banks in Canada.

3,241 Listeners

1,499 Listeners

806 Listeners

941 Listeners

529 Listeners

1,188 Listeners

2,183 Listeners

825 Listeners

1,428 Listeners

1,054 Listeners

9,715 Listeners

194 Listeners

829 Listeners

84 Listeners

50 Listeners

1,030 Listeners

49 Listeners